GLP-1 receptor agonists such as semaglutide and tirzepatide amplify the bodys GLP-1 response, restoring more normal signaling and offering substantial benefits for blood sugar regulation and sustainable weight loss
two compounds that address longevity and skin regeneration through complementary biological mechanisms, with Epitalon supporting cellular longevity through telomerase activation and GHK-Cu driving collagen synthesis, wound healing, and antioxidant protection
No published clinical studies were identified demonstrating appetite, metabolism, or weight-loss effects from transdermal herbal patches of this type
Compounded GLP-1 medications are not FDA-approved but are prepared in licensed facilities that meet FDA compliance and state pharmacy regulations
A literature review of CMMT reports identified across PubMed, Web of Science, Embase, and Scopus was also conducted